GBS is a rare condition in which a person's immune system attacks the peripheral nerves, resulting in muscle weakness, loss of sensation in the legs and/or arms, as well as problems swallowing or ...

Officials said that the tally of suspected and confirmed Gullain-Barre Syndrome (GBS) cases in Maharashtra reached 211 on ...

The tally of suspected and confirmed Gullain-Barre Syndrome cases in Maharashtra reached 211 on Tuesday with the detection of ...

Maharashtra has reported 211 cases of Gullain-Barre Syndrome, a serious nerve disorder. Out of these, 183 cases have been confirmed. The condition affects the peripheral nerves causing muscle weakness ...

Axogen, Inc. (NASDAQ:AXGN) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Axogen, Inc., together with its subsidiaries, develops and ...

French clinical-stage biotech AlgoTherapeutics (AlgoTx) today announced the completion of its 276 patient Phase II trial, known as ACT, with ATX01 in chemotherapy-induced peripheral neuropathy (CIPN).

AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing a first-in-class therapeutic for peripheral ...

Although GBS cannot always be prevented, maintaining a healthy diet can help reduce the risk of infections and support nerve ...

Guillain-Barré Syndrome (GBS) is a rare but potentially life-threatening neurological condition that can cause rapid muscle ...

Pancreatic cancer hijacks nerve cells to fuel tumor growth and resist therapy, researchers find. Blocking nerve signals ...

Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...